Search Results - "Tjellesen, L."

Refine Results
  1. 1

    Alendronate increases lumbar spine bone mineral density in patients with Crohn's disease by Haderslev, K.V., Tjellesen, L., Sorensen, H.A., Staun, M.

    Published in Gastroenterology (New York, N.Y. 1943) (01-09-2000)
    “…Background & Aims: Low bone mineral density (BMD) is a common complication of Crohn's disease and may lead to increased morbidity and mortality because of…”
    Get full text
    Journal Article
  2. 2

    Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection by Jeppesen, P B, Staun, M, Tjellesen, L, Mortensen, P B

    Published in Gut (01-12-1998)
    “…Background—H2 receptor blockers and proton pump inhibitors reduce intestinal output in patients with short bowel syndrome. Aims—To evaluate the effect of…”
    Get full text
    Journal Article
  3. 3

    Clinical, social and rehabilitation status of long-term home parenteral nutrition patients: results of a European multicentre survey by VAN GOSSUM, A., VAHEDI, K., ABDEL-MALIK, STAUN, M., PERTKIEWICZ, M., SHAFFER, J., HEBUTERNE, X., BEAU, P., GUEDON, C., SCHMIT, A., TJELLESEN, L., MESSING, B., FORBES, A.

    Published in Clinical nutrition (Edinburgh, Scotland) (01-06-2001)
    “…Background: Home parenteral nutrition (HPN) is a lifesaving treatment in patients with intestinal failure. Dependency of nutritional support becomes permanent…”
    Get full text
    Journal Article
  4. 4

    Assessment of the longitudinal changes in bone mineral density in patients receiving home parenteral nutrition by Haderslev, KV, Tjellesen, L, Haderslev, PH, Staun, M

    “…BACKGROUND: Low bone mineral density (BMD) is commonly reported in patients receiving home parenteral nutrition (HPN), but it remains unclear whether or not an…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Body Composition by Dual-Energy X-Ray Absorptiometry in Patients with Crohn's Disease by TJELLESEN, L, NIELSEN, P. K, STAUN, M

    “…Background: To study body composition at the whole-body level in patients with Crohn's disease and a history of intestinal resection compared with healthy…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Bone Mineral Content in Patients with Crohn's Disease: A Longitudinal Study in Patients with Bowel Resections by Staun, M., Tjellesen, L., Thale, M., Schaadt, O., Jarnum, S.

    “…Background: Low hone mineral content (BMC) has been reported in patients with inflammatory bowel disease. The aim of the present study was to measure BMC in…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Body Composition Changes Measured by Dual-Energy X-Ray Absorptiometry in Patients Receiving Home Parenteral Nutrition by Tjellesen, L., Staun, M., Nielsen, P. K.

    “…Background: To monitor changes in body composition in patients receiving home parenteral nutrition (HPN) and to ascertain whether changes were related to the…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Body composition in patients on home parenteral nutrition by Tjellesen, L, Staun, M, Rannem, T, Nielsen, P K, Jarnum, S

    “…Dual energy X-ray absorptiometry (DXA) measures and separates three of the principal compartments of the body, fat mass (FM), fat-free mass (FFM), comprising…”
    Get more information
    Journal Article
  14. 14

    Different metabolism of vitamin D2/D3 in epileptic patients treated with phenobarbitone/phenytoin by Tjellesen, L, Hummer, L, Christiansen, C, Rødbro, P

    Published in Bone (New York, N.Y.) (1986)
    “…Serum concentrations of vitamin D metabolites were measured before and during treatment with either vitamin D2 or vitamin D3, 4000 IU per day for 24 weeks, in…”
    Get more information
    Journal Article
  15. 15

    Representativity of regional to total bone mineral in healthy subjects and 'anticonvulsive treated' epileptic patients. Measurements by single and dual photon absorptiometry by Gotfredsen, A, Borg, J, Nilas, L, Tjellesen, L, Christiansen, C

    Published in European journal of clinical investigation (01-06-1986)
    “…Dual photon (153Gd) and single photon (125I) absorptiometry were used to measure the regional bone mineral content (BMC) and density (BMD), as well as the…”
    Get more information
    Journal Article
  16. 16

    Metabolism of vitamin D2 and vitamin D3 in patients on anticonvulsant therapy by Hartwell, D, Tjellesen, L, Christiansen, C, Rødbro, P

    Published in Acta neurologica Scandinavica (01-06-1989)
    “…We examined the effect of short-term treatment with pharmacological doses of vitamin D2 or vitamin D3 on the serum concentration of 1,25(OH)2D metabolites in…”
    Get more information
    Journal Article
  17. 17

    Effect of vitamin D2 and D3 on bone-mineral content in carbamazepine-treated epileptic patients by Tjellesen, L, Gotfredsen, A, Christiansen, C

    Published in Acta neurologica Scandinavica (01-12-1983)
    “…In order to clarify whether carbamazepine causes disturbances in calcium and bone metabolism were examined the effect of vitamin D2 or D3 in 30 epileptic…”
    Get more information
    Journal Article
  18. 18

    Serum vitamin D metabolites in epileptic patients treated with 2 different anti-convulsants by Tjellesen, L, Christiansen, C

    Published in Acta neurologica Scandinavica (01-09-1982)
    “…The serum concentrations of the vitamin D metabolites 25-hydroxyvitamin D (25OHD), 24,25-dihydroxyvitamin D (24,25(OH)2D), and 1,25-dihydroxyvitamin D…”
    Get more information
    Journal Article
  19. 19

    Different metabolism of vitamin D2 and vitamin D3 in epileptic patients on carbamazepine by Tjellesen, L, Christiansen, C, Rødbro, P, Hummer, L

    Published in Acta neurologica Scandinavica (01-05-1985)
    “…Serum concentrations of vitamin D metabolites were measured in 30 epileptic outpatients on monotherapy with carbamazepine before and during treatment with…”
    Get more information
    Journal Article
  20. 20